Introduction
Living with Primary biliary cholangitis (PBC) can be exhausting—especially when standard treatments no longer help. Symptoms like fatigue , discomfort, and itching (pruritus) can become part of daily life. That’s why Lucius Pharmaceuticals developed LuciSelade, a new once-daily pill for people whose PBC isn’t responding to common treatments like ursodeoxycholic acid (UDCA), or who struggle with its side effects.
Each LuciSelade capsule delivers 10 mg of seladelpar, a specially designed compound that helps your liver work more efficiently. It reduces bile acid buildup and eases inflammation by switching on liver receptors to restore balance. This can help relieve persistent symptoms like itchiness, tiredness, and abnormal liver test results.
What makes LuciSelade stand out is its targeted approach—it doesn’t just mask symptoms but addresses a key cause of PBC. With a simple daily capsule and a 30-day bottle, it fits easily into everyday life.
Supported by real scientific data and trusted by liver specialists, LuciSelade isn’t just a new medication—it’s a thoughtful, patient-centered therapy meant to enhance comfort, slow disease progression, and help people regain control of their health.
How LuciSelade Works
Understanding PBC
In PBC, the bile ducts inside the liver become inflamed and blocked, causing bile to build up. This toxic buildup damages liver cells, triggers inflammation, and over time, can lead to scarring (fibrosis). Traditional treatments like UDCA help many patients—but not everyone benefits or tolerates them well.
Seladelpar: A Targeted, Three‑Step Approach
- Slows Bile Production
Seladelpar activates a specific receptor in liver cells, increasing a natural hormone (FGF21) that reduces bile production. This eases the toxic buildup. - Helps Calm Inflammation
PBC involves the immune system attacking the bile ducts. Seladelpar helps “reset” immune cells in the liver, shifting them from an inflammatory state to a calmer one. This gives the liver a chance to heal. - Protects Against Scarring
It also affects cells that cause scarring (fibrosis), helping to slow or prevent further liver damage and improving long-term liver health.
Real Results You Can Feel
Together, these effects lead to:
- Lower amounts of bile in the liver
- Reduced inflammation
- Less scarring over time
- Better liver metabolism
Doctors track this progress using clear lab tests like alkaline phosphatase (ALP) and bilirubin levels. Patients often report feeling less itchy, more energetic, and overall better.
Proven in Clinical Trials
- Phase III trial results: Over 60% of people on LuciSelade reached their target ALP levels—compared to just 20% on a placebo.
- About 25% seeing their ALP levels return to normal, a result not seen with placebo.
- Many reported meaningful relief from itching and other symptoms.
- Most side effects were mild—many were similar to those seen in the placebo group.
Why LuciSelade Matters
- For patients: A simple one‑pill‑a‑day solution aimed at relieving symptoms and improving liver health—not just masking discomfort.
- For healthcare providers: Backed by strong clinical data, offering a trusted alternative for patients not responding to or tolerating UDCA.
- For quality of life: Provides hope, stability, and a sense of control—whether you’re newly diagnosed or managing PBC over time.
